Soluble guanylyl cyclase expression is reduced in allergic asthma

Andreas Papapetropoulos, Davina C.M. Simoes, Georgia Xanthou, Charis Roussos, Christina Gratziou

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Soluble guanylyl cyclase (sGC) is an enzyme highly expressed in the lung that generates cGMP contributing to airway smooth muscle relaxation. To determine whether the bronchoconstriction observed in asthma is accompanied by changes in sGC expression, we used a well-established murine model of allergic asthma. Histological and biochemical analyses confirmed the presence of inflammation in the lungs of mice sensitized and challenged with ovalbumin (OVA). Moreover, mice sensitized and challenged with OVA exhibited airway hyperreactivity to methacholine inhalation. Steady-state mRNA levels for all sGC subunits (α1, α2, and β1) were reduced in the lungs of mice with allergic asthma by 60-80%, as estimated by real-time PCR. These changes in mRNA were paralleled by changes at the protein level: α1, α2, and β1 expression was reduced by 50-80% as determined by Western blotting. Reduced α1 and β1 expression in bronchial smooth muscle cells was demonstrated by immunohistochemistry. To study if sGC inhibition mimics the airway hyperreactivity seen in asthma, we treated naïve mice with a selective sGC inhibitor. Indeed, in mice receiving ODQ the methacholine dose response was shifted to the left. We conclude that sGC expression is reduced in experimental asthma contributing to the observed airway hyperreactivity.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume290
Issue number1
DOIs
StatePublished - Jan 1 2006
Externally publishedYes

Fingerprint

Asthma
Methacholine Chloride
Ovalbumin
Lung
Messenger RNA
Muscle Relaxation
Bronchoconstriction
Inhalation
Smooth Muscle Myocytes
Smooth Muscle
Soluble Guanylyl Cyclase
Real-Time Polymerase Chain Reaction
Pneumonia
Western Blotting
Immunohistochemistry
Enzymes
Proteins

Keywords

  • Bronchoconstriction
  • Guanosine 3′,5′-cyclic monophosphate, airway hyperreactivity
  • Nitric oxide

ASJC Scopus subject areas

  • Physiology
  • Pulmonary and Respiratory Medicine
  • Physiology (medical)
  • Cell Biology

Cite this

Soluble guanylyl cyclase expression is reduced in allergic asthma. / Papapetropoulos, Andreas; Simoes, Davina C.M.; Xanthou, Georgia; Roussos, Charis; Gratziou, Christina.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 290, No. 1, 01.01.2006.

Research output: Contribution to journalArticle

Papapetropoulos, Andreas ; Simoes, Davina C.M. ; Xanthou, Georgia ; Roussos, Charis ; Gratziou, Christina. / Soluble guanylyl cyclase expression is reduced in allergic asthma. In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 2006 ; Vol. 290, No. 1.
@article{a5a545c25d7d4a6e863e3db1bdb5199d,
title = "Soluble guanylyl cyclase expression is reduced in allergic asthma",
abstract = "Soluble guanylyl cyclase (sGC) is an enzyme highly expressed in the lung that generates cGMP contributing to airway smooth muscle relaxation. To determine whether the bronchoconstriction observed in asthma is accompanied by changes in sGC expression, we used a well-established murine model of allergic asthma. Histological and biochemical analyses confirmed the presence of inflammation in the lungs of mice sensitized and challenged with ovalbumin (OVA). Moreover, mice sensitized and challenged with OVA exhibited airway hyperreactivity to methacholine inhalation. Steady-state mRNA levels for all sGC subunits (α1, α2, and β1) were reduced in the lungs of mice with allergic asthma by 60-80{\%}, as estimated by real-time PCR. These changes in mRNA were paralleled by changes at the protein level: α1, α2, and β1 expression was reduced by 50-80{\%} as determined by Western blotting. Reduced α1 and β1 expression in bronchial smooth muscle cells was demonstrated by immunohistochemistry. To study if sGC inhibition mimics the airway hyperreactivity seen in asthma, we treated na{\"i}ve mice with a selective sGC inhibitor. Indeed, in mice receiving ODQ the methacholine dose response was shifted to the left. We conclude that sGC expression is reduced in experimental asthma contributing to the observed airway hyperreactivity.",
keywords = "Bronchoconstriction, Guanosine 3′,5′-cyclic monophosphate, airway hyperreactivity, Nitric oxide",
author = "Andreas Papapetropoulos and Simoes, {Davina C.M.} and Georgia Xanthou and Charis Roussos and Christina Gratziou",
year = "2006",
month = "1",
day = "1",
doi = "10.1152/ajplung.00330.2005",
language = "English (US)",
volume = "290",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "1",

}

TY - JOUR

T1 - Soluble guanylyl cyclase expression is reduced in allergic asthma

AU - Papapetropoulos, Andreas

AU - Simoes, Davina C.M.

AU - Xanthou, Georgia

AU - Roussos, Charis

AU - Gratziou, Christina

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Soluble guanylyl cyclase (sGC) is an enzyme highly expressed in the lung that generates cGMP contributing to airway smooth muscle relaxation. To determine whether the bronchoconstriction observed in asthma is accompanied by changes in sGC expression, we used a well-established murine model of allergic asthma. Histological and biochemical analyses confirmed the presence of inflammation in the lungs of mice sensitized and challenged with ovalbumin (OVA). Moreover, mice sensitized and challenged with OVA exhibited airway hyperreactivity to methacholine inhalation. Steady-state mRNA levels for all sGC subunits (α1, α2, and β1) were reduced in the lungs of mice with allergic asthma by 60-80%, as estimated by real-time PCR. These changes in mRNA were paralleled by changes at the protein level: α1, α2, and β1 expression was reduced by 50-80% as determined by Western blotting. Reduced α1 and β1 expression in bronchial smooth muscle cells was demonstrated by immunohistochemistry. To study if sGC inhibition mimics the airway hyperreactivity seen in asthma, we treated naïve mice with a selective sGC inhibitor. Indeed, in mice receiving ODQ the methacholine dose response was shifted to the left. We conclude that sGC expression is reduced in experimental asthma contributing to the observed airway hyperreactivity.

AB - Soluble guanylyl cyclase (sGC) is an enzyme highly expressed in the lung that generates cGMP contributing to airway smooth muscle relaxation. To determine whether the bronchoconstriction observed in asthma is accompanied by changes in sGC expression, we used a well-established murine model of allergic asthma. Histological and biochemical analyses confirmed the presence of inflammation in the lungs of mice sensitized and challenged with ovalbumin (OVA). Moreover, mice sensitized and challenged with OVA exhibited airway hyperreactivity to methacholine inhalation. Steady-state mRNA levels for all sGC subunits (α1, α2, and β1) were reduced in the lungs of mice with allergic asthma by 60-80%, as estimated by real-time PCR. These changes in mRNA were paralleled by changes at the protein level: α1, α2, and β1 expression was reduced by 50-80% as determined by Western blotting. Reduced α1 and β1 expression in bronchial smooth muscle cells was demonstrated by immunohistochemistry. To study if sGC inhibition mimics the airway hyperreactivity seen in asthma, we treated naïve mice with a selective sGC inhibitor. Indeed, in mice receiving ODQ the methacholine dose response was shifted to the left. We conclude that sGC expression is reduced in experimental asthma contributing to the observed airway hyperreactivity.

KW - Bronchoconstriction

KW - Guanosine 3′,5′-cyclic monophosphate, airway hyperreactivity

KW - Nitric oxide

UR - http://www.scopus.com/inward/record.url?scp=33644805991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644805991&partnerID=8YFLogxK

U2 - 10.1152/ajplung.00330.2005

DO - 10.1152/ajplung.00330.2005

M3 - Article

VL - 290

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 1

ER -